Thursday, November 19, 2009

"Grease the skids" for whistleblowing!

A federal appeals court has ruled that Cell Therapeutics can pursue a claim for nearly $23 million against a former consultant that advised it to market a drug off-label, adding a whole new wrinkle to whistleblower lawsuits. Report

No comments: